Application of Omaha management model for patients with chronic obstructive pulmonary disease
10.3760/cma.j.issn.1672-7088.2018.07.002
- VernacularTitle:对慢性阻塞性肺疾病患者应用奥马哈管理模式的应用研究
- Author:
Jinna SHI
1
;
Tingting SONG
Author Information
1. 浙江中医药大学附属第二医院全科医学病区
- Keywords:
Pulmonary disease;
chronic obstructive;
Omaha system;
Disease evaluation
- From:
Chinese Journal of Practical Nursing
2018;34(7):485-488
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical intervention effect of Omaha on chronic obstructive pulmonary disease(COPD)patients by comparing the routine nursing measures of COPD and the nursing measures under the Omaha management mode. Methods Using experimental design method research in Omaha based management system, according to the inclusion and exclusion criteria, 70 patients with COPD were collected, and they were divided into observation group and control group of 35 cases by random digits table method. The control group was received routine nursing measures of COPD and the observation group was accepted nursing measures under the Omaha management mode.The incidence rate of nursing problems before and after hospitalization was observed. The chronic obstructive pulmonary disease assessment(CAT)was used to evaluate the patient's disease status at admission,discharge and 1 month after discharge. Results The problems with the incidence rate of not less than 20% were analyzed statistically.Except the role change,mental status,social status,skin,eyesight,substance abuse have no significant difference (P>0.05), the others were statistically significant (t =4.158-55.940, P <0.05).There was no significant difference in CAT score at admission,discharge between two groups(P>0.05). CAT score was (18.14 ± 1.01) points at 1 month after discharge in observation group and (20.17 ± 1.41) points in control group, the difference was statistically significant(t =6.890, P<0.05). Conclusions The application of nursing intervention in patients with COPD of the Omaha system, can achieve improving disease in patients with COPD,and make it easier for the patient's disease level of long-term stability,to provide new ideas and directions for further adjuvant therapy COPD.
